TY  - JOUR
AU  - Dilip Shah
AU  - Mamidala Venkata Ramamohan
AU  - Ketan Mehta
AU  - Vivek Shejole
AU  - S. Satyanarayana Murthy
AU  - Sachin Gupta
AU  - Anil Samaria
AU  - Bhavana Sosale
AU  - Yatindra Prasad Dube
AU  - Utsa Basu
AU  - Sagorika Mullick
AU  - Dinesh Agarwal
AU  - Venkateshwar Rao
AU  - Unnikrishnan Ambika Gopalakrishnan
AU  - Rahul Sahlot
AU  - Prabhat Kumar Agarwal
AU  - Sambit Das
AU  - Arjun Baidya
AU  - Indira Pattnaik
AU  - Shailaja Kale
AU  - Piyush Agarwal
AU  - Anuj Kumar Saini
AU  - Swarup Rajendra Wani
AU  - Eeshitha Ch
AU  - Jaganmohan Somagoni
TI  - A Randomized, Multicentric, Double-Blind, Active Controlled, Parallel Group, Phase III, Non-Inferiority Clinical Trial To Evaluate The Efficacy, Safety And Tolerability Of Oral Semaglutide Tablets Of Dr. Reddy’s Laboratories Ltd. Compared With Rybelsus® (Semaglutide) Tablets In Adult Patients With Inadequately Controlled Type 2 Diabetes Mellitus.
JO  - Journal of Clinical Endocrinology and Metabolism
PY  - 2026
DO  - 10.52338/jocem.2026.6017
ER  -